Pharmafile Logo

Top-10 ways that Pharma teams can fight the climate crisis

Ten easy steps that individual medical, marketing, clinical, regulatory, and market access teams can take to reduce their own footprints.

I recently attended a webinar called “Pharma’s climate goals: The roadmap to delivery.” It was an eye-opening discussion focused on the big changes that pharmaceutical organizations need to implement to reduce their carbon footprint. In this top-10 article, I wanted to build on the insights shared during that webinar, with a focus on the smaller–but just as important–steps that individual medical, marketing, clinical, regulatory, and market access teams can take to reduce their own footprints, contributing to their organizations’ bottom lines. These include:

1. Set clear short-, mid-, and long-term goals
2. Reduce your energy use or switch to sustainable sources of energy
3. Continue to let your team work remotely or flexibly
4. Consider decentralized trials
5. Take a critical look at your supply chain

Read the full top-10 list of ways that Pharma teams can reduce their environmental footprint and fight the climate crisis here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Effective Communication in Virtual Meetings: Stay Pithy - Impetus InSite Tips #4

Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today's fast-paced...

Enhancing Honesty in Feedback: Blinded Questions

Explore our third tip in our series aimed at refining asynchronous virtual meetings. Discover how using blinded questions can significantly minimize bias and enhance the integrity of feedback in virtual...

Streamlining Asynchronous Feedback: Scale Consistency - Impetus InSite Tips #2

Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable...

Clinical Trial Protocol Conceptualization: A Customer Story

To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical...

Mastering Asynchronous Meetings: Open-Ended Questions - Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges - Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives - Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...